Projects in Our Pipeline
Protecting Health, Promoting Life
Explore Our Stories
Insights Driving Kenya’s Vaccine Future.
Kenya BioVax Welcomes IVI Kenya and AVEC Africa Offices as Milestone for Vaccine Self-Reliance
Kenya BioVax Institute Limited (KBI) congratulates the International Vaccine Institute (IVI) and the…
French Minister Tours Kenya BioVax as Partners Reaffirm Support for Local Vaccine Manufacturing
The Kenya BioVax CEO, Dr Wesley Ronoh, briefs H.E. Éléonore Caroit, French Minister…
French National Assembly Delegation Visits KEMRI mRNA Laboratory Site to Strengthen Vaccine Manufacturing Partnerships
Members of Parliament from the National Assembly of France visited the ongoing mRNA…
Kenya BioVax Hosts RVMC Delegation to Advance Vaccine Fill-and-Finish Facility Readiness.
Strengthening Kenya’s vaccine manufacturing readiness requires sustained technical engagement, strategic collaboration, and shared…
Kenya BioVax and USP Sign MoU to Strengthen Quality Systems for Local Vaccine and Biologics Manufacturing
Kenya BioVax Institute CEO, Dr. Wesley Ronoh, exchanges a handshake and displays the…
Kenya BioVax Advances Local Manufacturing Agenda at EARGHSS 2026
Day 2 of the Eastern Africa Regional Global Health Security Summit (EARGHSS 2026)…
One Health in Action: Strengthening Vaccine Innovation and Collaboration
Kenya BioVax Institute Limited held a site visit and partnership meeting with Kenya…
About Us
Protecting Health, Promoting Life
Our Vision
A world free of vaccine-preventable diseases.
Our Mission
To manufacture and commercialize safe, effective and quality vaccines and other health products and improve access to affordable healthcare.
Core Values
Integrity, Innovation , Collaboration & Excellence.
Our Mandate
Actively seeking strategic partnerships in the development of human vaccines and other biotherapeutics.
Projects in
Our Pipeline
Successful Research
0+
Ongoing Research
0+
Experts on staff
0+
